mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.3 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.3 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.32 |
0.3 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |